Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and ExoskeletonsGlobeNewsWire • 05/08/25
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal ExoskeletonGlobeNewsWire • 04/29/25
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal ExoskeletonGlobeNewsWire • 04/24/25
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7Zacks Investment Research • 04/16/25
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 ExoskeletonZacks Investment Research • 03/17/25
Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk ExoskeletonGlobeNewsWire • 03/06/25
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home UseGlobeNewsWire • 03/05/25
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025GlobeNewsWire • 02/28/25
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational PrioritiesGlobeNewsWire • 01/13/25
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 01/08/25
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 01/07/25
Lifeward Announces Postponement of its Extraordinary General Meeting of ShareholdersGlobeNewsWire • 12/27/24
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to ExoskeletonsGlobeNewsWire • 11/19/24